Research output per year
Research output per year
Personal profile
Profile
I am a PhD student researching cellular immunity to HIV-1. Using single-cell omics, I study immune responses in individuals who respond to antiviral monoclonal antibody treatment, compared to non-responders. I hold a background in molecular medicine and have research experience in epigenetics, cancer biology, and immunology, with strong skills in both experimental and bioinformatic methods.
Job responsibilities
I work on quantification and in-depth characterization of HIV-1-specific T cells using spectral flow cytometry. I am involved in the design and analysis of experiments, with a particular focus on bioinformatic methods and data processing.
Areas of expertise
- Single cell cytometry
- Bioinformatics
- High dimensional data analysis
- HIV
- Antigen specific T cells
Fingerprint
Dive into the research topics where Lisa Loksø Dietz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy
on behalf of the ENFORCE Study Group, 15 Feb 2026, In: Vaccine. 73, 128155.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy
ENFORCE Study Group, 15 Feb 2026, In: Vaccine. 73, p. 128155Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2
Stærke, N. B., Andersen, S. D., Larsen, F. D., Baerends, E. A. M., Dietz, L. L., Østergaard, L., Tolstrup, M., Søgaard, O. S. & ENFORCE Study Group, 1 Sept 2024, In: International Journal of Infectious Diseases. 146, 107111.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access3 Citations (Scopus) -
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection
Juhl, A. K., Loksø Dietz, L., Schmeltz Søgaard, O., Reekie, J., Nielsen, H., Somuncu Johansen, I., Benfield, T., Wiese, L., Breinholt Stærke, N., Østergaard Jensen, T., Olesen, R., Iversen, K., Fogh, K., Bodilsen, J., Wulff Madsen, L., Olaf Lindvig, S., Raben, D., Dahl Andersen, S., Korning Hvidt, A. & Rode Andreasen, S. & 5 others, , 15 Sept 2024, In: The Journal of Infectious Diseases. 230, 3, p. e605-e615Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access4 Citations (Scopus) -
Utilizing immunotherapy towards achieving a functional cure for HIV-1
Sugiyama, F. H. C., Dietz, L. L. & Søgaard, O. S., Jul 2024, In: Current Opinion in HIV and AIDS. 19, 4, p. 187-193 7 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
3 Citations (Scopus)